Skip to main content

Indomethacin Extended-Release Capsules

Type of Posting: Revision Bulletin

Posting Date: 29–Dec–2011

Official Date: 01–Jan–2012

Expert Committee: Monographs—Small Molecules 2

Reason for Revision: Compliance

In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 2 Expert Committee has revised the Indomethacin Extended-Release Capsules monograph. The purpose for the revision is to add Dissolution Test 4 for a generic product approved by FDA.

The Indomethacin Extended-Release Capsules Revision Bulletin supersedes the currently official Indomethacin Extended-Release Capsules monograph. The Revision Bulletin will be incorporated in the Second Supplement to USP 35–NF 30.

Should you have any questions, please contact Clydewyn M. Anthony, Ph.D. (301-816-8139 or cma@usp.org).